PTCT logo

PTC THERAPEUTICS INC

PTCTNASDAQ
๐Ÿ† #1146 by market capEarnings Nov 2 ยท PostUS Equity
$72.98โ–ผ $0.71 (โˆ’0.97%)
Live
1hโ–ผ 0.1%
24hโ–ผ 1.0%
7dโ–ฒ 5.4%
14dโ–ผ 1.9%
30dโ–ผ 10.3%
1yโ–ฒ 61.2%
๐ŸฆMarket Cap
$6.09B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+114.5%
High Growth
๐Ÿ“ŠGross Margin
82.1%
High
๐Ÿ’ตFCF Margin
-33.0%
Thin
โš–๏ธP/S Ratio
6.1x
Fair
Otter Score
57
Weak
๐Ÿ“Š

Analyst Ratings

Price
$72.98
Total
26
Raised
5
Lowered
4
Avg PT
$105.43
H / L
$130 / $85
InstitutionActionRatingDate
Morgan Stanley
ReiteratedOverweight2026-07-31
Wells Fargo
ReiteratedOverweight2026-07-31
Cantor Fitzgerald
ReiteratedOverweight2026-07-16
RBC Capital
ReiteratedSector Perform2026-07-07
Jefferies
UpgradedHold โ†’ Buy2026-05-27
TD Cowen
UpgradedHold โ†’ Buy2026-05-08
B of A Securities
ReiteratedBuy2026-02-20
Barclays
UpgradedEqual Weight โ†’ Overweight2026-01-28
Citigroup
ReiteratedNeutral2025-11-05
Goldman Sachs
ReiteratedSell2025-11-05
Truist Securities
ReiteratedBuy2025-07-29
UBS
ReiteratedBuy2025-07-29
JP Morgan
ReiteratedOverweight2025-05-07
Baird
ReiteratedOutperform2025-05-07
Raymond James
DowngradedOutperform โ†’ Underperform2023-09-18
Credit Suisse
ReiteratedNeutral2023-07-20
SVB Leerink
ReiteratedMarket Perform โ†’ Perform2023-03-17
SunTrust Robinson Humphrey
ReiteratedBuy2020-07-21
Bank of America
UpgradedNeutral โ†’ Buy2019-05-13
Bernstein
ReiteratedOutperform2019-04-11
William Blair
UpgradedMarket Perform โ†’ Outperform2018-06-18
Wedbush
DowngradedOutperform โ†’ Neutral2016-03-01
Cowen & Co.
DowngradedOutperform โ†’ Market Perform2016-03-01
Oppenheimer
ReiteratedOutperform2016-02-25
Roth Capital
DowngradedBuy โ†’ Neutral2015-05-05
Deutsche Bank
ReiteratedBuy2015-04-09
One row per institution, most recent rating